Eric J. Velazquez, MD, is a Professor of Medicine at Duke University. As the section chief for Cardiovascular Imaging in the Division of Cardiology and the director of the Cardiac Diagnostic Unit and Echocardiography Laboratories for Duke University Health System, he coordinates a high-volume enterprise and an outstanding group of clinician-investigators and clinical staff who make important contributions across patient care, research and educational domains. As a long-time faculty leader in the Duke Clinical Research Institute, he manages the portfolio of Government-funded clinical trials. Dr. Velazquez is also a member of the Duke Global Health Institute and leads Duke's cardiovascular global health efforts. He is globally recognized as an authority in heart failure, cardiovascular clinical trials and cardiac imaging.
Dr. Velazquez's research interests include the evaluation and management of heart failure, particularly with coronary artery disease; hypertension; valve disease; and cardiovascular imaging. Dr. Velazquez has led global clinical trial operations for numerous cardiovascular clinical trial programs including VALIANT, ACCOMPLISH, the Heart Failure Network and STICH. He is currently the principal investigator for the NHLBI-funded STICHES Program and an NHLBI-funded Global Health Program for Chronic Cardiovascular Diseases in Eldoret, Kenya.
Dr. Velazquez has co-authored over 250 peer-reviewed publications, including recent publications in the New England Journal of Medicine, Journal of the American Medical Association, Circulation and European Heart Journal. He serves as Chair of the ASE Taskforce on International Echocardiography.
Feigal, JP, Boyle, SH, Samad, Z, Velazquez, EJ, Wilson, JL, Becker, RC, Williams, RB, Kuhn, CM, Ortel, TL, Rogers, JG, O'Connor, CM, and Jiang, W. "Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemia." Journal of psychosomatic research 93 (February 2017): 14-18.
Barasa, FA, Vedanthan, R, Pastakia, SD, Crowe, SJ, Aruasa, W, Sugut, WK, White, R, Ogola, ES, Bloomfield, GS, and Velazquez, EJ. "Approaches to Sustainable Capacity Building for Cardiovascular Disease Care in Kenya." Cardiology clinics 35, no. 1 (February 2017): 145-152. (Review)
Pokorney, SD, Miller, AL, Chen, AY, Thomas, L, Fonarow, GC, de Lemos, JA, Al-Khatib, SM, Velazquez, EJ, Peterson, ED, and Wang, TY. "Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction." Circulation 135, no. 1 (January 2017): 38-47.
Burroughs Peña, MS, Velazquez, EJ, Rivera, JD, Alenezi, F, Wong, C, Grigsby, M, Davila-Roman, VG, Gilman, RH, Miranda, JJ, and Checkley, W. "Biomass fuel smoke exposure was associated with adverse cardiac remodeling and left ventricular dysfunction in Peru." Indoor air (December 19, 2016).
Samad, Z, and Velazquez, EJ. "Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies." Current cardiology reports 18, no. 12 (December 2016): 128-. (Review)
Burroughs Peña, MS, Dunning, A, Schulte, PJ, Durheim, MT, Kussin, P, Checkley, W, and Velazquez, EJ. "Pulmonary function and adverse cardiovascular outcomes: Can cardiac function explain the link?." Respiratory medicine 121 (December 2016): 4-12.
Petrie, MC, Jhund, PS, She, L, Adlbrecht, C, Doenst, T, Panza, JA, Hill, JA, Lee, KL, Rouleau, JL, Prior, DL, Ali, IS, Maddury, J, Golba, KS, White, HD, Carson, P, Chrzanowski, L, Romanov, A, Miller, AB, and Velazquez, EJ. "Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure)." Circulation 134, no. 18 (November 2016): 1314-1324.
Dahhan, T, Siddiqui, I, Tapson, VF, Velazquez, EJ, Sun, S, Davenport, CA, Samad, Z, and Rajagopal, S. "Clinical and echocardiographic predictors of mortality in acute pulmonary embolism." Cardiovascular ultrasound 14, no. 1 (October 28, 2016)
Velazquez, EJ, and Bates, ER. "In CAD with LV dysfunction, adding CABG to medical therapy reduced all-cause and CV mortality at 10 years." Annals of Internal Medicine 165, no. 4 (August 16, 2016): JC15
Hunter, WG, Kelly, JP, McGarrah, RW, Khouri, MG, Craig, D, Haynes, C, Ilkayeva, O, Stevens, RD, Bain, JR, Muehlbauer, MJ, Newgard, CB, Felker, GM, Hernandez, AF, Velazquez, EJ, Kraus, WE, and Shah, SH. "Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure." Journal of the American Heart Association 5, no. 8 (July 29, 2016).PMID: 27473038